FKBP12.6 Antibodies

Santa Cruz Biotechnology features a diverse variety of FKBP12.6 monoclonal antibodies for research focused on understanding FKBP12.6's role in cellular processes. FKBP12.6 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FKBP12.6, a member of the FK506-binding protein family, plays a crucial role in regulating calcium signaling and modulating the activity of ryanodine receptors in muscle cells. The significance of FKBP12.6 extends to various physiological processes, including muscle contraction and cardiac function, making it an important target for studies related to heart diseases and muscle disorders. Understanding FKBP12.6 function can provide insights into the molecular mechanisms underlying these conditions. Research utilizing FKBP12.6 monoclonal antibodies has revealed important aspects of calcium channel regulation and its impact on muscle function. Ongoing studies continue to uncover new roles for FKBP12.6 in cellular signaling pathways. Current investigations are expanding knowledge about FKBP12.6's involvement in various physiological and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of FKBP12.6's role in health and disease.